Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/304% above fair value
$25.81+0.07 (+0.27%)
Close on Nov 13, 2026Market cap $13.35BP/E –Yield 2.01%
Baxter International total assets
Total assets on the balance sheet at the end of each period.
Baxter International's total assets was $19.41B at Sep 30, 2026. For fiscal 2025 it was $20.06B, down 22.2% from the year before. Over ten years it grew -0.4% a year on average. The highest annual figure on record is $33.52B in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.06B | -22.2% |
| FY2024 | Dec 31, 2024 | $25.78B | -8.8% |
| FY2023 | Dec 31, 2023 | $28.28B | -0.0% |
| FY2022 | Dec 31, 2022 | $28.29B | -15.6% |
| FY2021 | Dec 31, 2021 | $33.52B | +67.4% |
| FY2020 | Dec 31, 2020 | $20.02B | +10.0% |
| FY2019 | Dec 31, 2019 | $18.19B | +15.7% |
| FY2018 | Dec 31, 2018 | $15.72B | -8.1% |
| FY2017 | Dec 31, 2017 | $17.11B | +10.1% |
| FY2016 | Dec 31, 2016 | $15.55B | -25.8% |
| FY2015 | Dec 31, 2015 | $20.96B | -19.8% |
| FY2014 | Dec 31, 2014 | $26.14B | +3.6% |
| FY2013 | Dec 31, 2013 | $25.22B | +23.7% |
| FY2012 | Dec 31, 2012 | $20.39B | +6.9% |
| FY2011 | Dec 31, 2011 | $19.07B | +9.1% |
| FY2010 | Dec 31, 2010 | $17.49B | +0.8% |
| FY2009 | Dec 31, 2009 | $17.35B | +12.7% |
| FY2008 | Dec 31, 2008 | $15.41B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $19.41B | -7.8% |
| Q2 FY2026 | Jun 30, 2026 | $19.79B | -6.0% |
| Q1 FY2026 | Mar 31, 2026 | $19.85B | -6.8% |
| Q4 FY2025 | Dec 31, 2025 | $20.06B | -22.2% |
| Q3 FY2025 | Sep 30, 2025 | $21.07B | -21.0% |
| Q2 FY2025 | Jun 30, 2025 | $21.05B | -20.0% |
| Q1 FY2025 | Mar 31, 2025 | $21.30B | -23.3% |
| Q4 FY2024 | Dec 31, 2024 | $25.78B | -8.8% |
| Q3 FY2024 | Sep 30, 2024 | $26.68B | -13.0% |
| Q2 FY2024 | Jun 30, 2024 | $26.31B | -5.6% |
| Q1 FY2024 | Mar 31, 2024 | $27.79B | -1.8% |
| Q4 FY2023 | Dec 31, 2023 | $28.28B | -0.0% |
| Q3 FY2023 | Sep 30, 2023 | $30.66B | +9.6% |
| Q2 FY2023 | Jun 30, 2023 | $27.89B | -12.4% |
| Q1 FY2023 | Mar 31, 2023 | $28.29B | -13.5% |
| Q4 FY2022 | Dec 31, 2022 | $28.29B | -15.6% |
| Q3 FY2022 | Sep 30, 2022 | $27.97B | +41.2% |
| Q2 FY2022 | Jun 30, 2022 | $31.83B | +61.7% |
| Q1 FY2022 | Mar 31, 2022 | $32.72B | +68.1% |
| Q4 FY2021 | Dec 31, 2021 | $33.52B | +67.4% |
| Q3 FY2021 | Sep 30, 2021 | $19.81B | -1.4% |
| Q2 FY2021 | Jun 30, 2021 | $19.68B | +1.1% |
| Q1 FY2021 | Mar 31, 2021 | $19.47B | +2.0% |
| Q4 FY2020 | Dec 31, 2020 | $20.02B | +10.0% |
| Q3 FY2020 | Sep 30, 2020 | $20.10B | +16.2% |
| Q2 FY2020 | Jun 30, 2020 | $19.47B | +11.2% |
| Q1 FY2020 | Mar 31, 2020 | $19.08B | +17.4% |
| Q4 FY2019 | Dec 31, 2019 | $18.19B | +15.7% |
| Q3 FY2019 | Sep 30, 2019 | $17.30B | +3.0% |
| Q2 FY2019 | Jun 30, 2019 | $17.50B | +6.0% |
| Q1 FY2019 | Mar 31, 2019 | $16.24B | -3.6% |
| Q4 FY2018 | Dec 31, 2018 | $15.72B | -8.1% |
| Q3 FY2018 | Sep 30, 2018 | $16.80B | -4.2% |
| Q2 FY2018 | Jun 30, 2018 | $16.52B | -2.6% |
| Q1 FY2018 | Mar 31, 2018 | $16.84B | +7.6% |
| Q4 FY2017 | Dec 31, 2017 | $17.11B | +10.1% |
| Q3 FY2017 | Sep 30, 2017 | $17.54B | – |
| Q2 FY2017 | Jun 30, 2017 | $16.96B | – |
| Q1 FY2017 | Mar 31, 2017 | $15.66B | – |
| Q4 FY2016 | Dec 31, 2016 | $15.55B | – |
See a number that looks wrong?